FIELD: chemistry.
SUBSTANCE: compounds of the invention can be used for treating or preventing diseases and conditions, mediated by peroxisome proliferator activated gamma receptor (PPARγ). In formula (I) W represents a COOH group or -COOC-C1-C4alkyl; Y represents NH; Z represents S or O; X represents O; R1-R6 each independently represents a hydrogen atom or substitute, chosen from a group consisting of: C1-C4-alkyl, thienyl or phenyl, where phenyl is optionally substituted with one or more substitutes, independently chosen from a group consisting of C1-C4-alkyl, C1-C4-alkoxy, a halogen atom; -NO2 and -CN; A represents C1-C4-alkyl, -N(C1-C4-alkyl)-CO-C3-C7-cycloalkyl, aryl, chosen from a group consisting of phenyl, naphthyl, or heteroaryl, chosen from a group consisting of oxazolyl, isoxazolyl, thienyl, pyridyl, thiazolyl, thiadiazolyl, benzo[b]thienyl, imidazolyl, indolyl and carbazolyl, where aryl and heteroaryl are substituted or not substituted with one or more substitutes, independently chosen from a group consisting of C1-C4-alkyl, C1-C4-alkoxy, phenyl and a halogen atom; and n is an integer from 0 to 4. The invention also relates to a pharmaceutical composition, containing the invented compound as an active component, use of the compounds to make a medicinal agent, and method of treatment.
EFFECT: obtaining new biologically active compounds.
22 cl, 6 ex
Title | Year | Author | Number |
---|---|---|---|
NOVEL 3-PHENYLPROPIONIC ACID DERIVATIVES FOR TREATING DIABETES | 2005 |
|
RU2360906C2 |
2-ARYLPROPIONIC ACIDS AND DERIVATIVES, AND PHARMACEUTICAL COMPOSITIONS, CONTAINING THEREOF | 2009 |
|
RU2520212C2 |
ACYLAMINOTHIAZOLE DERIVATIVES, THEIR PREPARATION AND APPLICATION AS INHIBITORS OF B-AMILOYD PEPTIDES PRODUCTION | 2004 |
|
RU2360907C2 |
(HETERO)ARYL CYCLOPROPYLAMINE COMPOUNDS AS LSD1 INHIBITORS | 2012 |
|
RU2668952C2 |
ISOXAZOLINES AND ISOXAZOLES, METHOD OF INHIBITION OF PLATELET AGGREGATION, PHARMACEUTICAL COMPOSITION INHIBITING PLATELET AGGREGATION | 1994 |
|
RU2149871C1 |
METHOD OF TREATMENT OR PROPHYLAXIS OF MAMMALS AND HUMAN WITH VOMITING USING SOME QUINUCLIDINE, PIPERIDINE, AZANORBORNANE, ETHYLENEDIAMINE DERIVATIVES AND RELATED COMPOUNDS | 1994 |
|
RU2135179C1 |
PPAR-SUPPORTING COMPOUNDS FOR TREATING METABOLIC DISEASES | 2014 |
|
RU2687490C2 |
N-REPLACED BENZOSULPHONAMIDES | 2004 |
|
RU2364587C2 |
(HETERO)ARYL CYCLOPROPYLAMINE COMPOUNDS AS LSD1 INHIBITORS | 2012 |
|
RU2681211C2 |
PYRAZOLOPYRIDINES AND ANALOGUES THEREOF | 2004 |
|
RU2426734C2 |
Authors
Dates
2009-10-10—Published
2006-01-17—Filed